Home | All results_reference

[RDF data]
Results Reference #1053

Resource URI: http://static.linkedct.org/resource/results_reference/1053
linkedct:citation Lilenbaum R, Wang X, Gu L, et al.: Phase II randomized trial of docetaxel plus cetuximab or bortezomib in patients with advanced NSCLC and performance status (PS) 2: CALGB 30402. [Abstract] J Clin Oncol 25 (Suppl 18): A-7595, 408s, 2007.
rdfs:label Results Reference #1053
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00118183>
linkedct:results_reference_id 1053 (xsd:int)
rdf:type linkedct:results_reference